Skip to main content
BMRA logo

Biomerica, Inc.

BMRANASDAQHealthcareMedical Devices

$1.68Today:- (-)1Y −42.27%

As of Oct 22, 2026 close

Market cap
$5.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.45$3.20
Volume (live)
-
Avg. volume (3M)
20.60K

Biomerica (BMRA) Financial Ratios

For fiscal 2026 (fiscal year ended May 31, 2026), Biomerica had return on equity of -112.1% (down from -93.0%), debt-to-equity of 0.91 (up from 0.11), a current ratio of 1.62 (down from 2.80) and return on assets of -52.3% (down from -42.3%). A current ratio of 1.62 means current assets exceed current liabilities.

Biomerica Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Period endingMay 2026May 2025May 2024May 2023May 2022May 2021
Valuation Ratios
Forward P/E55.6255.6255.6255.6255.6255.62
P/S Ratio1.661.461.804.322.386.24
P/B Ratio2.811.891.481.975.404.87
Price/Tangible Book3.052.001.531.995.524.88
PEG Ratio4.324.324.324.324.324.32
Enterprise Value Ratios
EV/Revenue1.400.990.983.911.925.88
Profitability & Returns
Return on Equity (ROE)-112.10%-92.99%-65.28%-71.23%-51.63%-63.31%
Return on Assets (ROA)-52.35%-42.25%-33.57%-34.96%-24.44%-51.49%
Return on Invested Capital (ROIC)------106.94%
Return on Capital Employed (ROCE)-124.40%-122.20%-90.30%-57.70%-48.40%-57.03%
Leverage & Solvency Ratios
Debt/Equity0.910.110.120.090.170.14
Liquidity Ratios
Current Ratio1.622.803.516.584.697.10
Quick Ratio0.841.802.325.373.334.35
Efficiency Ratios
Asset Turnover0.700.700.460.411.630.50
Inventory Turnover2.562.492.172.195.652.26
Yield & Distribution Ratios
Earnings Yield-51.16%-64.05%-61.21%-30.98%-10.07%-
FCF Yield-46.36%-49.48%-55.41%-24.03%-1.19%-
Buyback Yield-26.90%-9.22%-18.87%-11.69%-6.24%-17.34%
Total Return------17.34%

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About Biomerica Financial Ratios

What is Biomerica's return on equity?

Biomerica's return on equity (ROE) was -112.1% for fiscal 2026 (period ended May 31, 2026). It was -93.0% a year earlier.

What is Biomerica's debt-to-equity ratio?

Biomerica's debt-to-equity ratio was 0.91 for fiscal 2026 (period ended May 31, 2026). It was 0.11 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition